2 completed. 2 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Completed 2 |
| Phase 2 | 1 | Completed 1 |
Follow Smithkline Beecham: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Phase I/II Study of Induction Chemotherapy With Daunorubicin, Cytarabine, Topotecan and Etoposide Cytarabine, Daunorubicin, Etoposide - Leukemia | Phase 1 / Phase 2 | Completed | H. Lee Moffitt Cancer Center and Research Institute | 41 | 1999-07-01 | 2012-09-25 |
| Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Multiple Myeloma etoposide phosphate, melphalan, topotecan - Multiple Myeloma, Plasma Cell Neoplasm | Phase 1 | Completed | H. Lee Moffitt Cancer Center and Research Institute | 131 | 1998-06-02 | 2019-11-08 |
Congenital Abnormalities (1) · Leukemia (1) · Leukemia, Erythroblastic, Acute (1) · Leukemia, Megakaryoblastic, Acute (1) · Leukemia, Monocytic, Acute (1) · Leukemia, Myeloid, Acute (1) · Leukemia, Myelomonocytic, Acute (1) · Multiple Myeloma (1) · Neoplasms, Plasma Cell (1)
Topotecan (2) · Cytarabine (1) · Daunorubicin (1) · Etoposide (1) · Melphalan (1) · etoposide phosphate (1)
United States (2)